Security key
55234L105
Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)
CUSIP: 55234L105
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 1,644,695
- Total 13F shares
- 42,358,020
- Share change
- +5,527,931
- Total reported value
- $221,955,861
- Put/Call ratio
- 0.95%
- Price per share
- $5.24
- Number of holders
- 60
- Value change
- +$29,996,377
- Number of buys
- 40
- Number of sells
- 10
Report period
Q4 2023
Institutions
60
Top holders
10
LYRA full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Lyra Therapeutics, Inc. SEC filings
Lyra Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55234L105
Recent filing periods:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
776%
|
12,757,562
|
$49,882,067 | — | 30 Sep 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
246%
|
4,050,218
|
$15,836,352 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
173%
|
2,848,564
|
$11,137,885 | — | 30 Sep 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
169%
|
2,780,261
|
$10,870,821 | — | 30 Sep 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
94%
|
1,550,000
|
$6,060,500 | — | 30 Sep 2023 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
86%
|
1,413,242
|
$5,525,776 | — | 30 Sep 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
76%
|
1,254,384
|
$4,904,641 | — | 30 Sep 2023 | |
| Venrock Adviser, LLC |
13F
|
Company |
56%
|
924,170
|
$3,613,505 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
53%
|
864,332
|
$3,379,538 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
38%
|
625,056
|
$2,443,969 | — | 30 Sep 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
36%
|
592,417
|
$2,316,350 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
19%
|
308,690
|
$1,207,287 | — | 30 Sep 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
18%
|
301,533
|
$1,178,994 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
16%
|
263,349
|
$1,029,695 | — | 30 Sep 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
14%
|
234,003
|
$914,952 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
9.9%
|
162,860
|
$636,783 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
8.6%
|
141,800
|
$554,438 | — | 30 Sep 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
8%
|
130,839
|
$511,580 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
7.7%
|
125,954
|
$492,480 | — | 30 Sep 2023 | |
| Clearline Capital LP |
13F
|
Company |
7.2%
|
119,128
|
$465,790 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.8%
|
95,080
|
$371,763 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
4.1%
|
67,677
|
$264,617 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.5%
|
57,009
|
$222,905 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3%
|
49,800
|
$195,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
47,482
|
$185,654 | — | 30 Sep 2023 | |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
|
Company |
1.9%
|
31,900
|
$124,729 | — | 30 Sep 2023 | |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.8%
|
30,000
|
$117,000 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
28,254
|
$110,473 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
1.2%
|
19,618
|
$77,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
18,621
|
$72,808 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
16,420
|
$64,202 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.41%
|
6,762
|
$26,439 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.2%
|
3,282
|
$12,833 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.2%
|
3,271
|
$13,000 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
1,500
|
$5,865 | — | 30 Sep 2023 | |
| COMERICA BANK |
13F
|
Company |
0.07%
|
1,159
|
$4,532 | — | 30 Sep 2023 | |
| Ameliora Wealth Management Ltd. |
13F
|
Company |
0.05%
|
750
|
$2,925 | — | 30 Sep 2023 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0.03%
|
500
|
$1,955 | — | 30 Sep 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
500
|
$1,955 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
296
|
$1,156 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
221
|
$864 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
200
|
$782 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
34
|
$133 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
18
|
$70 | — | 30 Sep 2023 | |
| NBVM GP, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
3,123,551
mixed-class rows
|
$7,473,948 | — | 31 May 2023 | |
| Edward T. Anderson |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
20,000
|
— | — | 30 Jun 2023 | |
| Corinne Noyes |
3/4/5
|
SVP of Commercial Strategy and Market Development |
—
mixed-class rows
|
91,667
mixed-class rows
|
$108,674 | — | 31 Jan 2023 | |
| Ph.D. Robert E. Richard |
3/4/5
|
SVP, Technical Operations |
—
mixed-class rows
|
75,000
mixed-class rows
|
$88,914 | — | 31 Jan 2023 | |
| Pamela E. Nelson |
3/4/5
|
SVP, Regulatory Affairs |
—
class O/S missing
|
30,000
|
— | — | 12 Feb 2022 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q4 2023
As of 31 Dec 2023,
Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,358,020 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Nantahala Capital Management, LLC, Vestal Point Capital, LP, Point72 Asset Management, L.P., CITADEL ADVISORS LLC, Samsara BioCapital, LLC, VR Adviser, LLC, Rosalind Advisors, Inc., PURA VIDA INVESTMENTS, LLC, and Ikarian Capital, LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
44
Q4 2023 holders
60
Holder diff
16
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.